Lumbar Spinal Fusion Policy
Policy governs medical necessity review and site-of-service determination for elective single-level lumbar spinal fusion in adults (age 19+), including indications, documentation requirements, coding, and definitions. It specifies conditions when single-level fusion may be considered medically necessary, conditions considered not medically necessary or investigational, and site-of-service criteria for elective surgical procedures.
Historical policy revisions clarified instability thresholds (e.g., addition of 4 mm translational instability in 09/11/12 history entry) and added CPT codes 22633 and 22634 on 01/11/12.
Annual literature reviews and guideline incorporations noted through 2024 references (NASS 2021, AAOS 2021, NICE 2017).
CPT codes 22633 and 22634 were added (01/11/12).
Policy statements extensively revised to clarify instability (added 4 mm translational instability), spinal stenosis, and pseudoarthrosis; failure of 6 months nonsurgical care removed from all policy statements (09/11/12).
Definitions for truncal imbalance, spondylolisthesis, and pseudoarthrosis added (multiple dates 2012-2016).
Smoking within the previous 6 weeks is a contraindication for lumbar spinal fusion; documentation of cessation required (04/14/15 update).
Diagnostic imaging (CT, MRI) must be performed within 12 months of surgery for documentation review (12/08/15).
CPT codes 22853, 22854, and 22859 added replacing deleted 22851 effective 01/01/17.
CPT code 62290 removed (10/01/17) and 0309T removed (01/01/19).
Policy title changed to 'Lumbar Spinal Fusion in Adults' and juvenile/adolescent scoliosis criteria removed (12/01/21).
Medically necessary statement for revision surgery for implant/instrumentation failure added effective for dates of service on or after September 2, 2022.
Multiple-level lumbar spinal fusion declared not medically necessary when criteria are not met for all levels (12/01/23).
Reorganized criteria for recurrent (same level) disc herniation to call out rapidly progressive symptoms of motor loss, neurogenic claudication, or cauda equina syndrome as stand-alone criteria (03/01/24).
Annual literature review updates noted repeatedly; most recent literature review through July 17, 2024 added (12/01/24).